Retsevmo 40 mg · CNK 4407557

Product information

Retsevmo 40 mg
168
4407557
0 / 10
Locked

Product properties

L01EX22
Eli Lilly Nederland
Capsule, hard
€7,224.00
EU/1/20/1527/007
00300021011550
M44
Public
587440-01

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Replacement by another medicinal product/pack) and no stock is available from wholesalers. Switching to an alternative is necessary.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Replacement by another medicinal product/pack

Alternative available
Available
Until 30/06/2026

Composition

4 ingredients

Substance Type Strength CAS
Active ingredient
40 mg
2152628-33-4
Excipient
Excipient
Excipient

Additional information

View on BCPI

Availability statistics

Commercialization stopped
31 days
3
0
01/07/2026